Cinacalcet Hydrochloride Patent Expiration
Cinacalcet Hydrochloride is Used for treating hyperparathyroidism and hypercalcemia by decreasing parathyroid hormone levels and modulating its secretion. It was first introduced by Amgen Inc
Cinacalcet Hydrochloride Patents
Given below is the list of patents protecting Cinacalcet Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Sensipar | US7829595 | Rapid dissolution formulation of a calcium receptor-active compound | Sep 22, 2026 | Amgen |
| Sensipar | US9375405 | Rapid dissolution formulation of a calcium receptor-active compound | Sep 22, 2026 | Amgen |
| Sensipar | US6011068 | Calcium receptor-active molecules |
Mar 08, 2018
(Expired) | Amgen |
| Sensipar | US6031003 | Calcium receptor-active molecules |
Dec 14, 2016
(Expired) | Amgen |
| Sensipar | US6313146 | Calcium receptor-active molecules |
Dec 14, 2016
(Expired) | Amgen |
| Sensipar | US6211244 | Calcium receptor-active compounds |
Oct 23, 2015
(Expired) | Amgen |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Cinacalcet Hydrochloride's patents.
Latest Legal Activities on Cinacalcet Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Cinacalcet Hydrochloride.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Nov, 2023 | US9375405 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 21 Apr, 2022 | US7829595 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 13 Dec, 2019 | US9375405 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 27 Apr, 2018 | US7829595 |
| Post Issue Communication - Certificate of Correction | 13 Feb, 2018 | US9375405 |
| Patent Issue Date Used in PTA Calculation Critical | 28 Jun, 2016 | US9375405 |
| Recordation of Patent Grant Mailed Critical | 28 Jun, 2016 | US9375405 |
| Issue Notification Mailed Critical | 08 Jun, 2016 | US9375405 |
| Dispatch to FDC | 25 May, 2016 | US9375405 |
| Application Is Considered Ready for Issue Critical | 25 May, 2016 | US9375405 |
Cinacalcet Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Cinacalcet Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Cinacalcet Hydrochloride. The first generic version for Cinacalcet Hydrochloride was by Cipla Ltd and was approved on Mar 8, 2018. And the latest generic version is by Jerome Stevens Pharmaceuticals Inc and was approved on Dec 2, 2021.
Given below is the list of companies who have filed for Cinacalcet Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 60MG BASE | tablet | Prescription | ORAL | AB | May 15, 2020 |
| EQ 90MG BASE | tablet | Prescription | ORAL | AB | May 15, 2020 |
| EQ 30MG BASE | tablet | Prescription | ORAL | AB | May 15, 2020 |
2. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 90MG BASE | tablet | Prescription | ORAL | AB | May 17, 2019 |
| EQ 30MG BASE | tablet | Prescription | ORAL | AB | May 17, 2019 |
| EQ 60MG BASE | tablet | Prescription | ORAL | AB | May 17, 2019 |
3. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 90MG BASE | tablet | Prescription | ORAL | AB | Mar 8, 2018 |
| EQ 30MG BASE | tablet | Prescription | ORAL | AB | Mar 8, 2018 |
| EQ 60MG BASE | tablet | Prescription | ORAL | AB | Mar 8, 2018 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
4. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 60MG BASE | tablet | Prescription | ORAL | AB | May 18, 2020 |
| EQ 30MG BASE | tablet | Prescription | ORAL | AB | May 18, 2020 |
| EQ 90MG BASE | tablet | Prescription | ORAL | AB | May 18, 2020 |
5. CIPLA
Cipla Ltd has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 30MG BASE | tablet | Prescription | ORAL | AB | Mar 8, 2018 |
| EQ 90MG BASE | tablet | Prescription | ORAL | AB | Mar 8, 2018 |
| EQ 60MG BASE | tablet | Prescription | ORAL | AB | Mar 8, 2018 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
6. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 60MG BASE | tablet | Prescription | ORAL | AB | Sep 18, 2020 |
| EQ 30MG BASE | tablet | Prescription | ORAL | AB | Sep 18, 2020 |
| EQ 90MG BASE | tablet | Prescription | ORAL | AB | Sep 18, 2020 |
7. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 90MG BASE | tablet | Prescription | ORAL | AB | Oct 7, 2020 |
| EQ 60MG BASE | tablet | Prescription | ORAL | AB | Oct 7, 2020 |
| EQ 30MG BASE | tablet | Prescription | ORAL | AB | Oct 7, 2020 |
8. LUPIN LTD
Lupin Ltd has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 60MG BASE | tablet | Discontinued | ORAL | N/A | Jun 28, 2019 |
| EQ 30MG BASE | tablet | Discontinued | ORAL | N/A | Jun 28, 2019 |
| EQ 90MG BASE | tablet | Discontinued | ORAL | N/A | Jun 28, 2019 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
9. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 90MG BASE | tablet | Discontinued | ORAL | N/A | Oct 16, 2018 |
| EQ 60MG BASE | tablet | Discontinued | ORAL | N/A | Oct 16, 2018 |
| EQ 30MG BASE | tablet | Discontinued | ORAL | N/A | Oct 16, 2018 |
10. PIRAMAL
Piramal Healthcare Uk Ltd has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Piramal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 30MG BASE | tablet | Prescription | ORAL | AB | Aug 1, 2018 |
| EQ 60MG BASE | tablet | Prescription | ORAL | AB | Aug 1, 2018 |
| EQ 90MG BASE | tablet | Prescription | ORAL | AB | Aug 1, 2018 |
11. STEVENS J
Jerome Stevens Pharmaceuticals Inc has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Stevens J.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG | tablet | Discontinued | ORAL | N/A | Dec 2, 2021 |
| 90MG | tablet | Discontinued | ORAL | N/A | Dec 2, 2021 |
| 30MG | tablet | Discontinued | ORAL | N/A | Dec 2, 2021 |
12. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 60MG BASE | tablet | Prescription | ORAL | AB | Apr 30, 2018 |
| EQ 90MG BASE
(reference standard) | tablet | Prescription | ORAL | AB | Apr 30, 2018 |
| EQ 30MG BASE | tablet | Prescription | ORAL | AB | Apr 30, 2018 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||
13. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 90MG BASE | tablet | Discontinued | ORAL | N/A | Oct 11, 2018 |
| EQ 60MG BASE | tablet | Prescription | ORAL | AB | Oct 11, 2018 |
| EQ 30MG BASE | tablet | Discontinued | ORAL | N/A | Oct 11, 2018 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
14. WATSON LABS TEVA
Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 90MG BASE | tablet | Prescription | ORAL | AB | Dec 27, 2018 |
| EQ 60MG BASE | tablet | Prescription | ORAL | AB | Dec 27, 2018 |
| EQ 30MG BASE | tablet | Prescription | ORAL | AB | Dec 27, 2018 |
15. ZYDUS PHARMS USA INC
Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Cinacalcet Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 90MG BASE | tablet | Prescription | ORAL | AB | Apr 23, 2018 |
| EQ 30MG BASE | tablet | Prescription | ORAL | AB | Apr 23, 2018 |
| EQ 60MG BASE | tablet | Prescription | ORAL | AB | Apr 23, 2018 |